In our study, we reconfirmed the impact of CYP2C19*2, *3 and P2RY12 rs6809699 polymorphisms on impaired antiplatelet effects of clopidogrel in Chinese CHD patients. This evidence concerns the gene CYP2C19 and coronary artery disorder.